GRUPO PAPELERO SCRIBE, S.A. DE C.V. – Trademark Portfolio

Entity Type: 03

GRUPO PAPELERO SCRIBE, S.A. DE C.V. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 16 (Paper Goods) — 4 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SCRIBE. The owner is based in Mexico D.F..

Jose Luis Lagrange No. 103, piso 12

Los Morales Polanco

Mexico D.F. C.P.11510 , MX

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SCRIBE
SCRIBE
Registered 2013
SCRIBE
SCRIBE
Cancelled 2011
MYPAP
MYPAP
Cancelled 2010
SCRIBE
SCRIBE
Cancelled 1963

Trademark Classifications

GRUPO PAPELERO SCRIBE, S.A. DE C.V.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

16
Paper Goods (4 filings)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

Frequently Asked Questions

How many trademarks does GRUPO PAPELERO SCRIBE, S.A. DE C.V. have?

GRUPO PAPELERO SCRIBE, S.A. DE C.V. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 cancelled.

What trademark classes does GRUPO PAPELERO SCRIBE, S.A. DE C.V. file in?

GRUPO PAPELERO SCRIBE, S.A. DE C.V. files trademarks across 1 Nice Classification class. The most active classes are Class 16 (Paper Goods). Class 16 covers paper and cardboard; printed matter; bookbinding material; photographs; stationery.

What are GRUPO PAPELERO SCRIBE, S.A. DE C.V.'s most well-known trademarks?

GRUPO PAPELERO SCRIBE, S.A. DE C.V.'s registered trademark portfolio includes well-known marks such as SCRIBE. These are among 1 currently registered trademark in the portfolio.

What is GRUPO PAPELERO SCRIBE, S.A. DE C.V.'s trademark registration success rate?

GRUPO PAPELERO SCRIBE, S.A. DE C.V. has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.